Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rabel Jaime David KantorfiledCriticalRabel Jaime David Kantor
Priority to ECSP972004priorityCriticalpatent/ECSP972004A/es
Publication of ECSP972004ApublicationCriticalpatent/ECSP972004A/es
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Una preparación farmacéutica de liberación programada de nifedipina en pequeños núcleos esféricos o glóbulos que logran IN-VIVO unos niveles en sangre regulados y terapéuticos y más concretamente se refiere a una formulación de Nifedipina para su administración una vez al día.
ECSP9720041997-01-171997-01-17Absorcion programada de una substancia farmaceutica 2,6- dimetil 4-(2 nitrofenil) -1,4- dihidropiridin- 3,5- dicarboxilato de dimetilo ( nifedipina)
ECSP972004A
(es)
Processo para a preparacao de 5-cloro-2-< { (3,4-dimetoxi-2-piridinil)-metil}-sulfinil>-1h-benzimidazol e de composicoes farmaceuticas que o contem
Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient
Preparacao que contem ingredientes activos e/ou agentes auxiliares com uma libertacao controlada destas substancias e a utilizacao e producao das mesmas
Comprimido de microgrânulos com baixa dosagem de princìpio ativo contendo um diluente diretamente compressìvel, composição, e, processo de preparação do comprimido